Clinical Trial Update: Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) (MK-8962-043) [Phase 3]

View source ↗

Summary

Phase 3 trial MK-8962-043 evaluated the efficacy and safety of corifollitropin alfa (MK-8962) in combination with hCG in adolescent males with hypogonadotropic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadotropic Hypogonadism

Drugs mentioned

• Corifollitropin alfa (MK-8962) (corifollitropin alfa)

Snippet

Sponsor: Organon and Co | Conditions: Hypogonadotropic Hypogonadism | Phase 3 | Status: COMPLETED | Results posted: 2021-04-08